|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-5-8
|
|
pubmed:abstractText |
Long-term activation of immunocompetent cells of the bladder wall as well as case reports of systemic infections some months or years after intravesical bacillus Calmette-Guerin (BCG) therapy imply that mycobacteria may persist in the body. Therefore. we investigated the fate of BCG in patients after uncomplicated intravesical instillation therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
165
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1765-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11342972-Adjuvants, Immunologic,
pubmed-meshheading:11342972-Administration, Intravesical,
pubmed-meshheading:11342972-BCG Vaccine,
pubmed-meshheading:11342972-Bacteremia,
pubmed-meshheading:11342972-DNA, Bacterial,
pubmed-meshheading:11342972-DNA, Ribosomal,
pubmed-meshheading:11342972-Humans,
pubmed-meshheading:11342972-Immunotherapy,
pubmed-meshheading:11342972-Mycobacterium bovis,
pubmed-meshheading:11342972-Polymerase Chain Reaction,
pubmed-meshheading:11342972-Sputum,
pubmed-meshheading:11342972-Urinary Bladder,
pubmed-meshheading:11342972-Urinary Bladder Neoplasms,
pubmed-meshheading:11342972-Urine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
The fate of bacillus Calmette-Guerin after intravesical instillation.
|
|
pubmed:affiliation |
Department of Urology, Medical University of Lübeck, National Reference Center for Mycobacteria, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
